Navigation Links
Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
Date:12/17/2007

VANCOUVER, Dec. 17 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its innovative, anti-infective 5-Fluorouracil-coated (5-FU) Central Venous Catheter (CVC).

"We are pleased to complete the submission of a 510(k) application to the FDA for our 5-FU CVC, as we believe this represents another important step towards commercializing this product line and developing our 5-FU anti-infective platform," said Dr. William Hunter, President and CEO of Angiotech.

Pending the receipt of all necessary regulatory approvals, Angiotech anticipates launching the commercial 5-FU CVC product line in 2008.

About Central Venous Catheters (CVC) and Catheter-Related Infections

Central venous catheters (CVC) are usually inserted into critically ill patients for extended periods of time to administer fluids, drugs, and nutrition, as well as facilitate frequent blood draws. One of the complications associated with CVC implantation is infection, which can occur when bacteria contaminate the catheter. CVC infections that progress to bloodstream infections, or septicemia, can become life threatening. In the U.S., the cost per catheter-related infection can range from $3,700 to $29,000(1). In addition, the Centers for Disease Control and Prevention (CDC) has raised concerns about the overuse of traditional antibiotics, which can contribute to an increase in the antibiotic resistance of bacteria.

About Angiotech's 5-FU CVC

Angiotech believes that 5-FU, a well-known and approved compound, has the potential to be used as a coat
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
11. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., , SAN MATEO, Calif., Nov. 24 /PRNewsw..., a biopharmaceutical company focused on developin...ies, announced today that Anthony DiTonno, Preside...esent at the 21st Annual Piper Jaffray Health Care...New York Palace Hotel in New York, New York. ,...
(Date:11/24/2009)... The FBI recently approved...oratories participating in or generating DNA recor... Madison, WI USA (PRWEB) -- The FBI ...S System for use by laboratories participating in...Index System (NDIS). NDIS currently contains more ...
(Date:11/24/2009)..., , DUBLIN, November 24 /PRNewswire-Fi... the global specialty biopharmaceutical company, t...European Medicines Agency for,velaglucerase alfa, ...pment,for the treatment of Type 1 Gaucher disease....lucerase alfa that has been submitted, with previo...
(Date:11/24/2009)..., BOZEN,Italy,November24/PRNewswire/--HealthR...ointventurewithagroupofselected,investors.Thisrece...nameHealthRoboticsCanada,Inc.andwillmarket,install...ept,whichincludesthe,revolutionaryproductofferings...oticsCanadaInc.willalsoprovideassistanceonan"asnee...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
..., Aug. 19 Omeros Corporation, a,Seattle-based cli...h AS, a,Norwegian human antibody therapeutics comp...n agreement for the discovery and development of f...MASP-2, or mannan-binding,lectin-associated serine...,system via the lectin pathway and is linked to mu...
...olio of Transfusion Solutions Offers Choice, ...ROCKAWAY, N.J., Aug. 18 Biotest Diagnostics Corpo...based Biotest AG, a worldwide,supplier of traditio...s,that it has received final clearance from the U....keting its full line of traditional blood,bank rea...
... 4C Controls Inc. (OTCBB: FOUR.OB) today announc...(Ret.) Dr. Philip Hayden as its Vice President, Se... NEW YORK (Business Wire EON) A... after a distinguished career with the Federal Bur...years involved in many aspects of law enforcement ...
Other Biology Technology:Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 2Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 3Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents 2Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents 3 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 2 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 3 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 4
(Date:11/24/2009)...rs to understanding how sounds associated with Nav...l or if they hear it at all. , The same type of...ses to detect flaws in the space shuttle,s behemot... peek inside the giant head of a whale. The scans ...of a whale,s hearing anatomy using a breakthrough ...
(Date:11/24/2009)... of Medical Toxicology (ACMT) have signed an agree...rnal of Medical Toxicology (JMT), the official jo...s previously published by the University of Pennsy...ogy , an international, peer-reviewed journal, is ... medical toxicology. The quarterly journal focuse...
(Date:11/24/2009)...) New research on bacterial communities throughou...table temporal patterns, suggesting that scientist...oring climate change in the polar regions. The stu... National Academy of Sciences Early Edition, show...fted synchronously over time, correlating with sea...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 1New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 2New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 3New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 4New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 5New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 6Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positive By Desig 57642 1Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positive By Desig 57642 2Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positive By Desig 57642 3AAA Members Save and Stay Healthy With Annual Eye Exams 57638 1AAA Members Save and Stay Healthy With Annual Eye Exams 57638 2AAA Members Save and Stay Healthy With Annual Eye Exams 57638 3
...Tulane National Primate Research Center has for th... agents in a vaginal gel protect the animals again... microbicide using compounds that inhibit the proc...ells could potentially provide a safe, effective a...men, according to study investigators. The study, ...
...anipulating the mosquitoes, sense of smell is the ...nderbilt University, that has been selected to rec...to Global Health. , The initiative, which was laun... just announced the selection of 43 "groundbreakin...ng countries that will receive a total of $436 mil...
...ty researchers have identified some of the key fac...d by multiple sclerosis (MS), complications of pre...he findings offer important clues about why the ne...ys that at least some forms of brain damage could ...st edition of the scientific journal Nature Medici...
Other Biology News:Vaginal gel may provide a new approach to HIV prevention 2Fighting malaria by manipulating mosquitoes' sense of smell 2Fighting malaria by manipulating mosquitoes' sense of smell 3Molecular Partners Required For Appropriate Neuronal Gene Repression 2Molecular Partners Required For Appropriate Neuronal Gene Repression 3Molecular Partners Required For Appropriate Neuronal Gene Repression 4
Z Amphetamine ELISA Kit, Single from Bio-Quant Inc.
Rat CGRP EIA Kit from Cayman Chemical
...RNA service provides the premium quality siRNAs yo...RNAs can be readily ordered online by providing ei...ng the sense and antisense siRNA sequences. (Also ... Pre-designed siRNAs, which are already designed f...
Custom siRNA, HPLC purified from Ambion
Biology Products: